CJC1295 NO DAC 5MG+ Ipamorelin 5MG

Dual Peptide System for Growth Hormone Pathway Research

🎁 FREE 3ml Bacteriostatic Water with Every Vial Purchased

Every peptide vial order automatically includes a complimentary 3ml vial of bacteriostatic water at no extra cost.

$101.99

Overview

CJC-1295 and Ipamorelin are synthetic peptides commonly studied together in growth hormone (GH) signaling and endocrine pathway research. Each peptide interacts with a distinct receptor system, making the combination a valuable model for examining coordinated GH release, pulsatility, and neuroendocrine signaling.

In research settings, this dual-peptide system is examined for its ability to engage both GHRH and ghrelin receptor pathways without receptor overlap, allowing precise investigation of GH-related signaling dynamics.

CJC-1295 / Ipamorelin is frequently referenced in endocrinology, metabolism, and recovery-focused research models due to its complementary mechanism design.

Mechanism of Action

CJC-1295 and Ipamorelin act on separate but synergistic growth hormone signaling pathways, making their combined study particularly useful in endocrine research.

Research indicates:

CJC-1295 interacts with:

Growth hormone–releasing hormone (GHRH) receptors
Pituitary GH signaling pathways
Prolonged GH signaling dynamics (depending on analog studied)

Ipamorelin interacts with:

Ghrelin (GHS-R) receptors
Pulsatile GH release signaling
Receptor-specific GH activation without broad endocrine stimulation

Unlike single-pathway models, this combination allows researchers to evaluate timing, amplitude, and coordination of GH signaling without direct receptor competition.

Research Applications

Growth Hormone Signaling Research

CJC-1295 / Ipamorelin is widely studied in GH pathway analysis:

GH release pattern modeling
Pulsatility and signal timing studies
Pituitary response characterization
Endocrine feedback loop evaluation

Metabolic & Endocrine Research

GH plays a central role in metabolic regulation, making this combination relevant for:

GH-mediated metabolic signaling
Energy balance pathway research
Endocrine system coordination studies

Hormonal rhythm analysis

Recovery & Regeneration Research

Growth hormone signaling is closely linked to recovery processes:

Post-exertion recovery markers
Tissue repair signaling pathways
Systemic recovery modeling
Neuroendocrine recovery dynamics

Sleep & Circadian Rhythm Research

GH secretion is closely tied to sleep architecture:

Sleep-linked GH pulse timing
Circadian rhythm alignment
Night-time endocrine signaling
Interaction between sleep stages and GH release

Age-Related Research

GH secretion patterns change with age, making this model relevant for:

Age-associated GH decline studies
Endocrine aging models
Hormonal rhythm disruption analysis
Longevity-related signaling research

Research Advantages

Why Researchers Study CJC-1295 / Ipamorelin

Dual-pathway GH signaling without receptor overlap
High specificity for GH-related pathways
Enables precise pulsatility and timing analysis
Common reference model in endocrine research
Suitable for long-term signaling studies

This combination is valued for its regulatory signaling design, rather than forced or non-specific endocrine activation.

IMPORTANT:
This product is exclusively intended for laboratory research purposes only.
Not approved for human consumption or veterinary use.
Not intended for diagnostic, therapeutic, or consumable applications.

Scientific References

Teichman SL, et al. “Prolonged stimulation of growth hormone secretion by CJC-1295.” J Clin Endocrinol Metab. 2006.
Patel K, et al. “Ipamorelin, a selective growth hormone secretagogue.” Endocrine. 1999.
Smith RG, et al. “Ghrelin receptor agonists and GH pulsatility.” Trends Endocrinol Metab. 2005.
Muller EE, et al. “Growth hormone secretagogues: physiology and clinical perspectives.” Endocr Rev. 2010.
Veldhuis JD, et al. “Endocrine control of growth hormone secretion.” Physiol Rev. 2001.